Login / Signup

Informal professionalization of healthy participants in phase I clinical trials in Russia.

Olga ZvonarevaIgor PimenovNatalia KutishenkoIgor MareevSergey MartsevichEvgeny Kulikov
Published in: Clinical trials (London, England) (2019)
A way of better protecting healthy trial participants begins with recognizing their skills, knowledge, and the centrality of the contribution they are making to pharmaceutical research. Currently, the expertise of experienced trial participants is recognized on the work floor only; therefore, the professionalization we described is informal. Yet, the informal professionalization process is inherently risky as it does not involve any change in the formal conditions of trial participants' work. Instituting formal measures for protecting healthy trial participants as skilled workers combined with recognition of their expertise is essential.
Keyphrases
  • clinical trial
  • phase iii
  • phase ii
  • study protocol
  • open label
  • randomized controlled trial
  • medical students